Japanese Agency for Medical Research and Development

The Japan Agency for Medical Research and Development (AMED), based in Chiyoda City, Tokyo, Japan, is an independent organization that funds and promotes medical research and development from basic science to clinical applications. It integrates R&D efforts previously handled by various ministries to advance new treatments, technologies, and healthcare solutions for public health. AMED allocates approximately 130 billion Japanese yen annually towards its research and development initiatives. The agency supports a broad ecosystem of researchers, universities, medical institutions, and industry partners across areas such as rare diseases, vaccine development, and healthcare innovation. Notable initiatives include the establishment of the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) in March 2022. The organization was established in April 2015.